JP Morgan Chase
HAO icon

JP Morgan Chase’s Haoxi Health Technology Ltd HAO Stock Holding History

JP Morgan Chase’s Portfolio HAO Stock Details HAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1
Closed -$98 – 7725
2025
Q1 		$98 Buy
+1
New +$297 ﹤0.01% 6879
2024
Q4 		– Hold
0
– -$1 – 7779
2024
Q3 		– Hold
0
– – – 7381
2024
Q2 		– Hold
0
– -$18 – 7798
2024
Q1 		– Hold
0
– – – 7181

Other funds holding HAO

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase's HAO Position: Q2 2025 in Review

JP Morgan Chase sold out of Haoxi Health Technology Ltd (HAO) in Q2 2025, closing a stake of 1 share — an estimated $98 sold.

JP Morgan Chase first reported a position in HAO in Q1 2025 and held it in 1 quarter. The position peaked at $98 in Q1 2025. 2 funds tracked by Wall St. Rank hold HAO as of Q2 2025.

  • JP Morgan Chase reported no remaining Haoxi Health Technology Ltd position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 1 Haoxi Health Technology Ltd share in Q2 2025, an estimated $98.
  • JP Morgan Chase first reported a position in Haoxi Health Technology Ltd in Q1 2025 and held it in 1 quarter.
  • JP Morgan Chase's Haoxi Health Technology Ltd position peaked at $98 in Q1 2025.
  • 2 funds tracked by Wall St. Rank held Haoxi Health Technology Ltd as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.